| Literature DB >> 34041188 |
Sushil K Shukla1, Divyta Sachan1, Prashant K Bajpai1, Dhiraj K Srivastava1, Manoj K Verma1, Tanya Agarwal1.
Abstract
INTRODUCTION: An estimated 2.25 million new cancer cases with 7 lakh cancer deaths were reported, according to GLOBOCAN 2018 in India. There is a steady rise in cancer cases, but trends and patterns vary within the state depending on the geographic region.Entities:
Keywords: Cancer; ICD-10 classification; carcinoma; malignancy; neoplasm; tumor
Year: 2021 PMID: 34041188 PMCID: PMC8140243 DOI: 10.4103/jfmpc.jfmpc_1468_20
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Figure 1Distribution of females according to ICD-10 classification from 2015 to 2018 (N = 2036)
Figure 4Age wise trend of cancer cases among different age groups
Age-wise distribution of cancer with the maximum frequency of cases (top five)
| Age Groups ( | |||||
|---|---|---|---|---|---|
| 0-14 years | 15-64 years | 65 years and above | |||
| Colon | 16 (19%) | Breast | 818 (27.3%) | Lungs | 141 (26.4%) |
| Rectum | 8 (9.5%) | Cervix | 302 (10.1%) | Gall bladder | 1209 (5.0%) |
| Leukemia | 8 (9.5%) | Lungs | 251 (8.4%) | Breasts | 45 (8.4%) |
| Lip/oral cavity | 8 (9.5%) | Lip/oral cavity | 245 (8.2%) | Lip/oral cavity | 31 (5.8%) |
| Brain/CNS | 7 (8.3%) | Gall bladder | 209 (7.0%) | Prostate | 24 (4.5%) |
Distribution of cancer patients as the ICD 10 classification on ICD 10 classification
| Organ based on ICD-10 classification | Frequency (%) | ||
|---|---|---|---|
| Male | Female | Total | |
| Salivary Glands | 25 (1.6) | 11 (0.5) | 36 (1.0) |
| Oropharynx | 86 (5.4) | 5 (0.2) | 91 (2.5) |
| Nasopharynx | 2 (0.1) | 1 (0.0) | 3 (0.1) |
| Lip, Oral Cavity | 247 (15.7) | 37 (1.8) | 284 (7.9) |
| Hypopharynx | 12 (0.8) | 1 (0.0) | 13 (0.4) |
| Esophagus | 18 (1.1) | 11 (0.5) | 29 (0.8) |
| Stomach | 18 (1.1) | 4 (0.2) | 22 (0.6) |
| Colon | 67 (4.2) | 45 (2.2) | 112 (3.1) |
| Rectum | 42 (2.7) | 26 (1.3) | 68 (1.9) |
| Anus | 5 (0.3) | 5 (0.2) | 10 (0.3) |
| Liver | 26 (1.6) | 10 (0.5) | 36 (1.0) |
| Gall Bladder | 128 (8.1) | 161 (7.9) | 289 (8.0) |
| Pancreas | 32 (2.0) | 20 (1.0) | 52 (1.4) |
| Larynx | 51 (3.2) | 16 (0.8) | 67 (1.9) |
| Lung | 288 (18.3) | 106 (5.2) | 394 (10.9) |
| Melanoma Of The Skin | 3 (0.1) | 1 (0.0) | 4 (0.1) |
| NMSC | 5 (0.3) | 3 (0.1) | 8 (0.2) |
| Mesothelioma | 1 (0.1) | 1 (0.0) | 2 (0.1) |
| Kaposi Sarcoma | 2 (0.1) | 1 (0.0) | 3 (0.1) |
| Female Breast | 0 (0.0) | 866 (42.5) | 866 (24.0) |
| Vulva | 0 (0.0) | 5 (0.2) | 5 (0.1) |
| Vagina | 0 (0.0) | 2 (0.1) | 2 (0.1) |
| Cervix Uteri | 0 (0.0) | 313 (15.4) | 313 (8.7) |
| Corpus Uteri | 0 (0.0) | 11 (0.5) | 11 (0.3) |
| Ovary | 0 (0.0) | 162 (8.0) | 162 (4.5) |
| Penis | 22 (1.4) | 0 (0.0) | 22 (0.6) |
| Prostate | 42 (2.7) | 0 (0.0) | 42 (1.2) |
| Testis Scrotum Epididymis | 18 (1.1) | 0 (0.0) | 18 (0.5) |
| Kidney | 26 (1.6) | 7 (0.3) | 33 (0.9) |
| Bladder And Ureter | 54 (3.4) | 9 (0.4) | 63 (1.7) |
| Brain/Central Nervous System | 35 (2.5) | 22 (1.1) | 57 (1.6) |
| Thyroid | 4 (0.3) | 12 (0.6) | 16 (0.4) |
| Hodgkin Lymphoma | 19 (1.2) | 2 (0.1) | 21 (0.6) |
| Non-Hodgkin Lymphoma | 97 (6.1) | 29 (1.4) | 126 (3.5) |
| Multiple Myeloma | 12 (0.8) | 3 (0.1) | 15 (0.4) |
| Leukemia | 47 (3.0) | 22 (1.1) | 69 (1.9) |
| Others | 144 (9.1) | 106 (5.2) | 250 (6.9) |
| Total | 2036 | 1578 | 3614 |
Figure 5Year wise trend of malignancies from 2015 to 2018